In consideration of the coronavirus situation, this event has been cancelled for April 5, 2020. It will be rescheduled for October 2020. Speakers * Vendors * Free Healthy Lunch * Raffle Prizes Explore steps you can take to improve your own health. (Cancelled for April 5) 12:00 pm to 3:00 pm Elmhurst Memorial… Read more »
On October 27, 2019, Conquer Myasthenia Gravis hosted its Fall Patient Seminar. Speakers: Click to see these videos from the seminar. And keep reading below for seminar highlights. Clinical Trials: What MG patients need to know – Rabia Malik, MD Clinical Trials Q&A: What Patient, Doctor &… Read more »
As of January 2020, a number of clinical drug trials are recruiting participants. Details about these studies can be found at www.clinicaltrials.gov. Biotech companies also may have a webpage dedicated to the therapy they are studying. Sponsor: argenx BVBA. A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Trial to Evaluate the Efficacy, Safety and Tolerability of… Read more »
Conquer MG is excited to share news that the National Institutes of Health (NIH) has awarded a team at the George Washington University (GW) $7.8 million to establish a rare disease network for myasthenia gravis. Conquer MG will join scientists and physicians from academic institutions, other patient advocacy groups, and biotech/pharma companies, to better understand… Read more »
Sunday, October 27, 2019 FALL PATIENT SEMINAR “Myasthenia Gravis and Clinical Trials” Rabia Malik, MD, Rush University Medical Center Angela Pontius, Ra Pharmaceuticals Palos Hospital Auditorium 12251 S. 80th Avenue, Palos Heights, IL Parking: Visitor Garage 2, Opposite Main Entrance (Click here) “Prednisone has too many side effects. My MG… Read more »
